Nuance Investments LLC raised its holdings in Globe Life Inc. (NYSE:GL - Free Report) by 8.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,234,069 shares of the company's stock after acquiring an additional 95,091 shares during the quarter. Globe Life comprises approximately 5.6% of Nuance Investments LLC's holdings, making the stock its 4th largest position. Nuance Investments LLC owned about 1.47% of Globe Life worth $137,623,000 at the end of the most recent quarter.
Several other large investors also recently added to or reduced their stakes in the business. Private Trust Co. NA grew its holdings in Globe Life by 12.5% during the fourth quarter. Private Trust Co. NA now owns 754 shares of the company's stock valued at $84,000 after purchasing an additional 84 shares during the last quarter. Pinnacle Wealth Planning Services Inc. grew its stake in Globe Life by 4.0% in the 4th quarter. Pinnacle Wealth Planning Services Inc. now owns 2,293 shares of the company's stock valued at $256,000 after buying an additional 88 shares during the last quarter. EverSource Wealth Advisors LLC raised its holdings in Globe Life by 32.7% in the 4th quarter. EverSource Wealth Advisors LLC now owns 365 shares of the company's stock worth $41,000 after acquiring an additional 90 shares during the period. New Mexico Educational Retirement Board lifted its position in Globe Life by 2.4% during the 4th quarter. New Mexico Educational Retirement Board now owns 4,233 shares of the company's stock worth $472,000 after acquiring an additional 100 shares during the last quarter. Finally, Erste Asset Management GmbH lifted its position in Globe Life by 3.7% during the 4th quarter. Erste Asset Management GmbH now owns 2,800 shares of the company's stock worth $307,000 after acquiring an additional 100 shares during the last quarter. 81.61% of the stock is owned by institutional investors.
Analysts Set New Price Targets
A number of equities analysts have recently commented on the company. Keefe, Bruyette & Woods lifted their price objective on Globe Life from $137.00 to $145.00 and gave the stock an "outperform" rating in a research note on Wednesday, February 12th. Jefferies Financial Group raised their target price on Globe Life from $107.00 to $114.00 and gave the company a "hold" rating in a report on Tuesday, December 10th. Evercore ISI upgraded Globe Life from an "in-line" rating to an "outperform" rating and upped their price target for the stock from $132.00 to $143.00 in a report on Wednesday, January 8th. Morgan Stanley increased their price objective on Globe Life from $125.00 to $126.00 and gave the company an "equal weight" rating in a research report on Friday, February 28th. Finally, BMO Capital Markets began coverage on shares of Globe Life in a research note on Thursday, January 23rd. They set a "market perform" rating and a $114.00 target price for the company. Five equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, Globe Life has an average rating of "Moderate Buy" and a consensus target price of $135.60.
Get Our Latest Stock Analysis on Globe Life
Insider Activity at Globe Life
In related news, CMO Jennifer Allison Haworth sold 9,000 shares of the firm's stock in a transaction that occurred on Monday, January 6th. The shares were sold at an average price of $112.91, for a total value of $1,016,190.00. Following the completion of the sale, the chief marketing officer now owns 13,485 shares of the company's stock, valued at $1,522,591.35. This trade represents a 40.03 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Mark A. Blinn sold 3,000 shares of the business's stock in a transaction that occurred on Monday, January 6th. The stock was sold at an average price of $113.23, for a total transaction of $339,690.00. Following the completion of the transaction, the director now owns 5,122 shares of the company's stock, valued at $579,964.06. This trade represents a 36.94 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 61,338 shares of company stock valued at $7,239,630 in the last three months. Corporate insiders own 1.51% of the company's stock.
Globe Life Price Performance
Globe Life stock traded down $1.77 during mid-day trading on Friday, hitting $129.65. 422,841 shares of the company were exchanged, compared to its average volume of 1,432,484. The company has a market capitalization of $10.79 billion, a PE ratio of 10.85 and a beta of 0.77. The business has a fifty day moving average of $123.98 and a 200 day moving average of $113.91. Globe Life Inc. has a 1-year low of $38.95 and a 1-year high of $131.98. The company has a quick ratio of 0.05, a current ratio of 0.05 and a debt-to-equity ratio of 0.50.
Globe Life (NYSE:GL - Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $3.14 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.12 by $0.02. Globe Life had a net margin of 18.53% and a return on equity of 22.32%. As a group, sell-side analysts expect that Globe Life Inc. will post 13.87 earnings per share for the current year.
Globe Life Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Thursday, May 1st. Investors of record on Thursday, April 3rd will be given a dividend of $0.27 per share. The ex-dividend date is Thursday, April 3rd. This is a positive change from Globe Life's previous quarterly dividend of $0.24. This represents a $1.08 dividend on an annualized basis and a yield of 0.83%. Globe Life's dividend payout ratio is 9.04%.
Globe Life Profile
(
Free Report)
Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
Further Reading

Before you consider Globe Life, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globe Life wasn't on the list.
While Globe Life currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.